Future research should explore the comprehensive genetic landscape, including additional polymorphisms such as TNF-α -238G/A, and investigate the therapeutic modulation of cytokines to enhance treatment efficacy and patient prognosis in ALL. This evidence concerns the gene TNF and acute lymphoblastic leukemia.